|
⚲
|
| Keyboard |
| Scott John K Jr
✚
|
|
|---|---|
| CIK # | 0001753763 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001753763] | |
| 4 | [0001753763] | |
| SC 13D | [0001753763] | |
| SC 13G | [0001753763] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Scott John K Jr | Navidea Biopharmaceuticals Inc | [2019-06-24] |
| Scott John K Jr | Navidea Biopharmaceuticals Inc | [2018-09-24] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Scott John K Jr | |
| Navidea Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Navidea Biopharmaceuticals Inc NAVB
Series I Convertible Preferred Stock · derivative
|
2023-11-27 | Other | 2,400 | $1,000.00 | 2,400,000 |
|
Navidea Biopharmaceuticals Inc NAVB
Series J Convertible Preffered Stock · derivative
|
2023-11-27 | Other | 64,289 | $100.00 | 6,428,900 |
|
Navidea Biopharmaceuticals Inc NAVB
Series G Redeemable Preferred Stock
|
2023-11-27 | Other | 2,270 | ||
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2023-06-29 | Grant | 12,200,000 | $0.09 | 1,098,000 |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2023-06-05 | Grant | 11,508,672 | ||
|
Navidea Biopharmaceuticals Inc NAVB
Series J Convertible Preferred Stock · derivative
|
2023-06-05 | Conversion | 11,969 | $100.00 | 1,196,900 |
|
Navidea Biopharmaceuticals Inc NAVB
Series J Convertible Preferred Stock · derivative
|
2023-06-01 | Buy | 11,969 | $100.00 | 1,196,900 |
|
Navidea Biopharmaceuticals Inc NAVB
Series G Redeemable Preferred Stock
|
2023-06-01 | Other | 990 | ||
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-11-30 | Grant | 1,250 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-10-31 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-09-30 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-08-31 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Warrant to Purchase Common Stock · derivative
|
2022-08-30 | Buy | 2,400 | ||
|
Navidea Biopharmaceuticals Inc NAVB
Series F Redeemable Convertible Preferred Stock · derivative
|
2022-08-30 | Sell | 1,740 | $1,379.31 | 2,399,999 |
|
Navidea Biopharmaceuticals Inc NAVB
Series I Convertible Preferred Stock · derivative
|
2022-08-30 | Buy | 2,400 | ||
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-07-31 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-06-30 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-05-31 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2022-04-30 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Series F Redeemable Convertible Preferred Stock · derivative
|
2022-04-10 | Buy | 1,740 | $0.80 | 1,392 |
| showing 20 of 35 most recent transactions | |||||